Table 1.
Demographic and medical characteristics of women who completed questionnaire (n=1588). N (%).
| HIV+ N=1123 | HIV− N=465 | P-valuea | |
|---|---|---|---|
| Age at interview (years) | |||
| <30 | 58 (5.2) | 79 (17.0) | <0.0001 |
| 30–39 | 310 (27.6) | 147 (31.6) | |
| 40–49 | 476 (42.4) | 155 (33.3) | |
| 50+ | 279 (24.8) | 84 (18.1) | |
| Ethnicity | |||
| Non-Hispanic African-American | 628 (55.9) | 282 (60.7) | 0.07 |
| Hispanic | 308 (27.4) | 116 (24.9) | |
| Non-Hispanic White | 147 (13.1) | 44 (9.5) | |
| Other | 40 (3.6) | 23 (4.9) | |
| Average household income | |||
| ≤ =$6,000 | 185 (18.0) | 102 (24.2) | 0.009 |
| $6,001–$12,000 | 323 (31.5) | 102 (24.2) | |
| $12,001–$18,000 | 146 (14.2) | 56 (13.3) | |
| $18,001+ (missing=140) | 373 (36.3) | 161 (38.3) | |
| Education level | |||
| Less than high school | 424 (37.8) | 164 (35.3) | 0.40 |
| Completed high school | 323 (28.8) | 149 (32.1) | |
| Some college/college degree (missing=3) | 374 (33.4) | 151 (32.5) | |
| Site/location | |||
| Bronx | 168 (15.0) | 91 (19.6) | 0.03 |
| Brooklyn | 272 (24.2) | 110 (23.6) | |
| DC | 169 (15.0) | 61 (13.1) | |
| Los Angeles | 219 (19.5) | 78 (16.8) | |
| San Francisco | 147 (13.1) | 78 (16.8) | |
| Chicago | 148 (13.2) | 47 (10.1) | |
| Alcohol use | |||
| Abstainer | 716 (63.8) | 230 (49.5) | <0.0001 |
| Light (<3 drinks/week) | 294 (26.2) | 147 (31.6) | |
| Moderate/heavy (3+ drinks/week) | 113 (10.0) | 88 (18.9) | |
| Current smoker | 441 (39.3) | 225 (48.4) | 0.0008 |
| Injection drug use status | |||
| Current user | 19 (1.7) | 11 (2.4) | 0.01 |
| Former user | 258 (23.0) | 77 (16.5) | |
| Never | 846 (75.3) | 377 (81.1) | |
| Non-injection drug use status | |||
| Current user | 222 (19.8) | 147 (31.6) | <0.0001 |
| Former user | 535 (47.6) | 226 (48.6) | |
| Never | 366 (32.6) | 92 (19.8) | |
| CES-D score | |||
| Mean | 13.9 | 12.7 | 0.06b |
| Median | 11.0 | 9.0 | 0.07c |
| Range | 0–58 | 0–53 | |
| Depressive symptoms based on CES-D score (16+) (missing=5) | 436 (38.9) | 162 (35.1) | 0.15 |
| English WRAT score (number of words pronounced correctly) | |||
| Mean | 28.8 | 28.7 | 0.77b |
| Median | 31.0 | 29.0 | 0.43c |
| Range | 3–42 | 8–42 | |
| Spanish WAT score (number of words pronounced correctly) | |||
| Mean | 23.3 | 19.3 | 0.14b |
| Median | 26.0 | 19.0 | 0.21c |
| Range | 0–30 | 4–30 | |
| Lifetime nadir CD4 lymphocyte count (cells/cmm) | |||
| <200 | 514 (45.8) | ||
| 200–500 | 529 (47.1) | ||
| >500 | 80 (7.1) | ||
| CD4 lymphocyte count (cells/cmm) at visit | |||
| <200 | 157 (14.0) | ||
| 200–500 | 443 (39.4) | ||
| >500 | 523 (46.6) | ||
| Viral load at visit | |||
| Mean | 16,158.0 | ||
| Median | 80 | ||
| Range (missing=12) | 80–2,100,000 | ||
| HAARTd use at visit For questionnaire | 740 (65.9) | ||
a
P-value obtained by using the chi-square test unless otherwise specified.
b
P-value obtained by using the t-test for means.
c
P-value obtained using the Wilcoxon two-sample test.
d
Highly active antiretroviral therapy.